ISPUB.com / IJTWM/10/1/14357
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Third World Medicine
  • Volume 10
  • Number 1

Original Article

Comparative Analysis Of Vascular Access For Haemodialysis In End-Stage Renal Disease In A Developing And Developed Country.

E Arodiwe, J Eze

Keywords

developed country., developing country, end stage renal disease, haemodialysis, vascular access

Citation

E Arodiwe, J Eze. Comparative Analysis Of Vascular Access For Haemodialysis In End-Stage Renal Disease In A Developing And Developed Country.. The Internet Journal of Third World Medicine. 2012 Volume 10 Number 1.

Abstract


Background: End Stage Renal disease (ESRD) is an important and growing medical problem all over the world especially in developing countries. Securing adequate vascular access is an essential part of managing affected patients. Objectives: To compare vascular access routes for haemodialysis in a developed and developing country setting.Method: Case notes were studied for information on age, gender, vascular access routes at University of Nigeria teaching hospital (UNTH) from January to July 2000. Operation lists and case notes used at Texas Heart Institute (THI) from October 2005 to March 2006 were reviewed to provide the above information. The findings were compared. Result: One hundred and fifty nine and Ninety four patients at THI and UNTH respectively were studied. There was similar gender pattern among patients seen at both institutions. The mean age in years of patients with ESRD requiring haemodialysis was lower at UNTH (44.6±17.1 as against 56.2±14.8 in THI), p<0.001. Direct femoral vein cannulation was the main vascular access route in UNTH (93.6%), whereas left hand arteriovenous graft (AVG) was the commonest route at THI (34.6%). Conclusion: We conclude that the prevalent vascular routes differ in these two centers with THI having a well established renal replacement protocol. The important challenges at UNTH include inadequate manpower, general poverty of the patients, lack of vascular access creation materials and unavailability of organized health policy for patients with ESRD in Nigeria. These problems are common in most developing countries.

 

This paper was presented at the 51 st Annual General Meeting and Scientific Conference of West African College of Surgeons, Dakar Senegal on July 3, 2011.

Introduction

End Stage Renal Disease (ESRD) is a significant and growing medical problem in the United States of America1 and indeed all over the world, especially in the developing countries such as Nigeria2. Securing vascular access is an essential part of any haemodialysis (HD) programme. In December 31, 1999, the point prevalence of patients with ESRD receiving HD was 209,637 and this number increased by approximately 4.2% per year between 1995 and 19993. The first arteriovenous fistula (AVF) constructed for haemodialysis access was created by Kenneth Apple in February 1965 at the Bronx Veterans Administration Hospital in collaboration with James Cimino, and Nephrologists Michael Brescia and Baruch Hurwich4. Before this, dialysis access was possible only by direct needle cannulation of large vessels or by a Scribner external vascular shunt.

End stage renal failure patients requiring long term haemodialysis need a durable vascular access. Various types are available. This study compares what obtains in a typical Nigerian setting, a resource challenged environment with that of an institution in the United States of America.

Methods

This study was a comparative retrospective one examining the route of vascular access for chronic haemodialysis in the University of Nigeria Teaching Hospital (UNTH), Enugu and Texas Heart Institute (THI), Houston, USA. One of the authors was on a one year clinical cardiovascular surgery fellowship at the THI. This offered the opportunity to obtain data from THI. From UNTH relevant information which included age, gender, vascular access type and vessels used were obtained from the case notes of the patients involved in the study. The period studied at THI was from October 2005 to March 2006, while at UNTH, January to July 2000. Acute cases that required emergency dialysis through any available access route were not included in this study. THI was using cannulation of left subclavian, right internal jugular or femoral vein as the case may be for these cases.

Data analysis was done using the statistical package for social sciences (SPSS) version 17.0. Comparison of proportions was done using the chi-square test(x2). Continuous variables were compared using the Analysis of Variance (ANOVA). P value <0.05 was considered statistically significant.

Results

Within the period of study, a total of 159 and 94 patients with ESRD were seen at THI and UNTH respectively.

The mean age of patients with ESRD undergoing haemodialysis was significantly higher in THI than UNTH (56.2±14.8 and 44.6±17.1, p<0.001). The age range was 18 – 88 years in Texas and 13 – 83 years in Enugu. There was no gender difference between patients seen at both centers (Table I).

Figure 1
Table I. Characteristics of study population

Right femoral vein cannulation was the commonest type of vascular access route in Enugu, Nigeria (93.6%) while left hand Arteriovenous Graft (AVG) was the commonest vascular access route in Texas (34.6%), Tables IIA and B.

Figure 2
Table II. Vascular Access Types. II A. UNTH, ENUGU NIGERIA

Figure 3
Table IIB. TEXAS HEART INSTITUTE (THI), HOUSTON, USA.

Out of the 159 patients who had vascular access within the stated period at THI, 27(17%) had revision of their vascular access for various reasons. Left hand graft and right hand fistula were the commonest revision sites each accounting for 18.5% respectively, (Table III).

Figure 4
Table III. Vascular Access for Revised Cases (THI).

Plain revision of the vascular access was the commonest procedure for the revised cases accounting for 77.8%, followed by ligation procedure which accounted for 14.8%. Exploration/revision and revision/thrombectomy accounted for 3.7% respectively of revision procedures, (Table IV).

Figure 5
Table IV. Procedure for revised cases.

Discussion

End stage renal disease (ESRD) remains a significant and growing medical problem all over the world. Before the advent of dialysis, the prognosis was uniformly poor. Invention of dialysis therapy has changed the history of this disease. Securing vascular access is an essential part of any haemodialysis programme. Before the landmark publication of Brescia et al5 in 1966, dialysis access was possible only by direct needle cannulation of large vessels or by Scribner external vascular shunt. During the following decades, various vascular access procedures have been used, such as variations of more proximal and complex fistulas, snuff-box fistulas, trans-positions, vascular grafts ( both synthetic and biologic) implantable access devices, shunts, catheters, and more.6-8

In this study for chronic haemodialysis in these two centers, the utilization of access routes were compared. More people utilized these facilities in a developed country setting (Texas, USA). The underdeveloped country setting ( Enugu, Nigeria) still depend more on direct femoral vein cannulation while in the developed country setting, grafts and fistulas are more commonly used.

There are several reasons for these discrepancies in the utilization of vascular access route in the developing world like Nigeria. There is a dearth of appropriate technology and materials for vascular surgery. Poverty, ignorance, and relative high cost of treatment are also additional factors. Where manpower and other materials are available, poor quality vessels in limbs make surgery difficulty resulting in high failure rates. Most of the vessels were destroyed due to repeated venipuncture prior to surgery.

Unites States of America (USA) has a renal data system that shows situation report of the disease9. This data shows in atlas form as well as in writing what need to be known thereby keeping the country aware of what is happening. There is nothing like that in Nigeria and most countries in sub-Saharan Africa. Our government is yet to buy the idea of including treatment of ESRD in the National Health Insurance Scheme or set up a committee to study the prevalence of ESRD among our population of over 150 million people.

The patients with ESRD in Enugu, Nigeria were younger at presentation. This is likely due to aetiological factors such as infective processes leading to chronic glomerulonephritis. These are important causes of ESRD 2, 10,11 in developing world than in the United States where diseases like diabetes mellitus is the commonest cause.12 It is also known that life expectancy is shorter in developing countries.

With the availability of advanced technology, guided venous cannulation under fluoroscopy has become the order of the day in developed countries13. Fluoroscopy during and after catheter placement allows accurate placement of the catheter tip and ensures that the catheter is not kinked. Ultrasound guidance is the standard of care for all haemodialysis catheter insertions, but this is not so in Nigeria. The radiology unit in our hospital needs to be involved. Ultrasound –guided catheter placement in the internal jugular vein increased success rate, decreased complication rates and reduced catheter associated infections13. More arteriovenous graft (AVG) and arteriovenous fistula (AVF) were done in a developed country setting (Texas, USA). This is because there is a good and well organized haemodialysis programme already integrated into the health system of the country. The cost of providing this treatment is high, but health insurance scheme which is hardly available or functional or comprehensive enough in developing countries, help to relieve the patients the financial burden in developed countries. The minimum wage in Nigeria is $100, while the cost of haemodialysis in Nigeria is between $100 to $200. The cost implication for the average patient with ESRD becomes very clear.

In both centers, more males were undergoing haemodialysis treatment although this is not statistically significant. The reason for this is not easily known. Could it be that more males are utilizing haemodialysis services or does it have to do with cultural orientation? There could be individual patient factors (such as morbidity), physician based factors, and patient factors that have to do with traits and cultural factors14. Coordinated effort is needed to handle this issue.

Direct venous cannulation of the right femoral vein was the commonest vascular access route in Enugu, Nigeria. It can be used for emergency haemodialysis but it is not suitable for chronic haemodialysis. The complications of haematoma and pseudoaneurysms are high with direct venous cannulation. Double lumen catheterization of the internal jugular or subclavian vein was the procedure of choice in Texas during emergency situations and before the maturation of AVF or AVG. it is most times introduced under fluoroscopic guide. Chan et al 15 has reviewed catheter use and provided comprehensive update of tunneled haemodialysis catheters, their necessity and pitfalls, and novel direction for future investigations.

Left upper limb access routes which were either grafts or fistulae form the main sites for haemodialysis access in Texas. This is most likely because of the dominant nature of the right upper limb. Use of the left upper limb leaves the patient with a non-restricted functional upper limb. In Enugu, Nigeria, these routes were hardly utilized. Current guidelines recommend native AVF as the vascular access of choice for haemodialysis on account of the lower incidence of complications16. The fistula access, while at times less successful in the immediate short term, is always the preferred long-term access type because of its greater longevity, fewer interventions for maintenance, and lower infection rates.

Grafts and fistulas could develop problems needing revision. In the Texas situation, 18.5% of left hand graft and right hand fistula cases respectively were revised, while 14.8% of left hand fistulas needed revision. Early failure of AVF occurs mainly in forearm sites among women and diabetic patients. Surgical expertise has also a significant influence17. The probability of primary failure is strongly related to the centre of access creation, suggesting an important role for the vascular surgeon’s skills and decisions18.

AV fistula surgery requires use of size 6-0 or 7-0 prolene suture and surgical loop for clearer vision. This loop has never been used at UNTH; Enugu before this study and as a result of this and other technical problems, the outcome for AVF has not been good. The surgeon should focus on sites distally on the extremity; reserving proximal sites for potential future access insertions should initial access site fail16. Arterio-venous grafts have some advantages in the guideline. Synthetic materials were used throughout in all the cases at THI. While the majority of past experience with prosthetic grafts has been with the use of Polytetrafluoroethylene (PTFE), other prosthetics (e.g. polyurethane) and biological conduits (bovine) have been used recently with similar outcomes. The choice of synthetic or biological material should be based on the surgeon’s experience and preference. The choice of synthetic or biological conduits should consider local experience, technical details, and cost.

Conclusion

This study demonstrated that younger patients were affected by ESRD in Enugu, Nigeria compared to Texas, USA. The most common access route in Enugu for haemodialysis was repeated femoral vein cannulation which is not only crude but also not a permanent measure. This is likely to be the situation in most poor resource environment. Poverty, unavailability of comprehensive health insurance package, unavailability of vascular access creation materials and adequately trained doctors to perform the required surgery are important factors determining the vascular access route.

This calls for government, institutional, pharmaceutical and people with philanthropic disposition to come to the rescue in these resource challenged environments where the incidence of chronic kidney disease is rising dangerously.

Acknowledgement

We wish to thank the surgical associates of Texas, P.A., Texas Heart Institute that accommodated one of the authors throughout the one year Surgical Fellowship and particularly Charles H. Hallman, M.D, for his personal interest and for allowing us to collect the data used for this study.

References

1. Susan I, O’Shea MD, Jeffrey HL, et al: Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. J Vasc Surg 2003; 38: 541-8.
2. Naicker S. End-stage renal disease in Sub-Saharan and South Africa: Kidney Int. 2003; 63(83); S119-S122.
3. US Renal data system. USRDS 2001 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National institutes of health, National institutes of Diabetes and Digestive and Kidney Diseases: 2001.
4. Brescia MJ, Cimino JE, Appell K, et al: Chronic haemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966; 275: 1089-1092.
5. Center for Medicare and Medicaid Services (CMS): CMS launches breakthrough initiative for major improvement in care for kidney patients: safe vascular access through collaborative fistula first initiative. March 17, 2005. http://www.cms. Available at http//:www.cms.hhs.gov/apps/media/press/release.asp? Counter=1386. Accessed December 16, 2008.
6. Dagher F, Gelber R, Ramos E, et al: The use of basilic vein and brachial artery as A-V fistula for long term haemodialysis. J Surg Res 1976; 20:373-376.
7. Grace KC, Ing TS, Sound LS, et al: Proximal forearm fistula for maintenance haemodialysis. Kidney int 1977; 11:71-75.
8. Glickman MH, Stokes GK, Ross JR, et al: Multicenter evaluation of a polytetrafluoroethylene vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in haemodialysis applications. J Vasc Surg 2001, 34:465-473.
9. US Renal Data System USRDS. 2011. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Health: Institute of Diabetes and Digestive and Kidney Diseases, 2011.
10. Bamgboye EL. Haemodialysis management problems in developing countries with Nigeria as a surrogate: Kidney Int. 2003; 63-119.
11. Akinsola W, Odesanmi WO, Ogunniyi JO, et al: Diseases causing chronic renal failure in Nigerians – a prospective study of 100 cases. Afr J Med Sci 1989; 18:131-135.
12. Rychlik I, Miltenberger-Miltenyi G, Ritz E: The drama of the continuous increase in end-stage renal failure patients with type 2 diabetes mellitus. Nephrol Dial Transplant. 1998; 13:6-10.
13. Costanza MJ, Amankwah KS, Khan MA, et al: Angioaccess for Haemodialysis. Current problems in Surgery. Volume 48(7). Edited by Ashley SW. New York: Mosby; 2011: 438-441.
14. Polkinghorne K. Vascular access in Australia and New Zealand: Some answers and questions. Euro J Vasc Endovasc Surg 2004 (28): 583-589.
15. Chan MR, Yevzlin AS. Tunneled dialysis catheters: recent trends and future directions. Adv Chronic Kidney Dis 2009; 16: 386-95.
16. Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J.
Kidney Dis 2006: 48: S176-247.
17. Ernandez T, Saudan P, Berney T, et al. Risk factors for early failure of native arteriovenous fistulas. Nephron Clin Pract 2005. 101: C39-44.
18. Huijbregts HJ, Bots ML, Moll FL, et al. Hospital specific aspects predominantly determine primary failure of haemodialysis arteriovenous fistulas. J Vasc Surg 2007; 45: 962-7.

Author Information

Ejikeme B. Arodiwe
Department of Medicine, Renal Unit, University of Nigeria Teaching Hospital

John C. Eze
Department of Surgery, Cardiothoracic Unit, University of Nigeria Teaching Hospital

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy